STC Technologies' Orasure for cannabanoids:
This article was originally published in Clinica
STC Technologies has added its cannabanoids micro-plate enzyme immunoassay to its group of OraSure tests that have received FDA marketing clearance. The test is used for the detection of marijuana in oral fluid collected with the OraSure oral specimen collection device manufactured by Epitope under an agreement between the two companies.
You may also be interested in...
Formal dispute resolution was key element in four-month turnaround from rejection by US FDA to approval for golodirsen, the second Sarepta DMD drug to clear the agency after appearing to have minimal prospects.
Correvio’s attempt to move vernakalant from 'clinical hold' to 'FDA approved' was a huge long shot. But the advisory committee vote – and looming FDA rejection – are another indication that real-world data is not a panacea.